Skip to content
WeighLab
Menu
Ranked #77 · Grade C

Goldspan Health review

Goldspan Health sells compounded semaglutide at $229 and tirzepatide at $299 every 28 days, with daily sublingual and low-dose versions of both at lower prices, through a storefront operated by a different company.

Visit Goldspan Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$229 every 28 days month-to-month (13 charges a year, not 12)
Tirzepatide
$299 every 28 days month-to-month (13 charges a year, not 12)
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$2,748

Tirzepatide · modeled / year

$3,588

Pricing verified September 2026

The Index scorecard

Goldspan Health scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month56/100
Price Transparency86/100
Nationwide Access86/100
Formulation Options77/100
Clinical Oversight68/100
Contract Flexibility45/100

Where the value is

  • Prices ten separate GLP-1 products openly — injection and sublingual, standard and low dose, with a B12 or a glycine base — before any account
  • Each plan card itemizes what the figure buys: the clinician evaluation, the medication, injection supplies, two-day shipping and clinical-team access
  • States the billing cycle honestly on the plan card and the order timeline as 28 days and four weeks
  • Names a medical director and two clinical advisors with their specialties
  • Says which pharmacy class dispenses — "licensed under U.S. FDA §503A or §503B" — even though it does not name the pharmacy

The tradeoffs

  • The hero prints "/month" over a plan billed every 28 days, which is 13 charges a year rather than 12
  • "Pause, delay, or cancel at any time" sits against a refund policy reading "all sales are final" and storefront terms saying an order cannot be canceled once placed
  • The tirzepatide low-dose sublingual page lists "Compounded sublingual semaglutide microdose" among what the price includes — the wrong molecule on a product page
  • No pharmacy is named, and Goldspan publishes no legal entity, address or governing law of its own
  • The certification seal shown belongs to the storefront's domain, not to goldspanhealth.com
  • "IN 50 STATES" on the homepage sits against terms saying some therapies are unavailable in certain states, with no list either way
  • Two of the sublingual full-dose products are sold on the storefront but are not linked from the weight-loss page a reader arrives on

The bottom line

Best for: Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12. Goldspan Health sells compounded semaglutide at $229 and tirzepatide at $299 every 28 days, with daily sublingual and low-dose versions of both at lower prices, through a storefront operated by a different company.

Ranked #77 of 529 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 528 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Goldspan Health.

The 21 programs nearest this one

Pricing, states and verification reflect Goldspan Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Goldspan Health's site. Not medical advice; see our disclosure.

← Back to the value leaderboard